Arcoma Past Earnings Performance
Past criteria checks 5/6
Arcoma's earnings have been declining at an average annual rate of -22.2%, while the Medical Equipment industry saw earnings growing at 6.3% annually. Revenues have been growing at an average rate of 3.2% per year. Arcoma's return on equity is 17.8%, and it has net margins of 5.5%.
Key information
-22.2%
Earnings growth rate
-22.9%
EPS growth rate
| Medical Equipment Industry Growth | 6.2% |
| Revenue growth rate | 3.2% |
| Return on equity | 17.8% |
| Net Margin | 5.5% |
| Next Earnings Update | 15 Aug 2024 |
Recent past performance updates
Recent updates
Is Now The Time To Look At Buying Arcoma AB (STO:ARCOMA)?
Apr 26
Arcoma AB's (STO:ARCOMA) P/E Is Still On The Mark Following 25% Share Price Bounce
Feb 06Is Arcoma (STO:ARCOMA) A Risky Investment?
Jan 15We Think Arcoma (STO:ARCOMA) Is Taking Some Risk With Its Debt
Sep 11Is Arcoma (STO:ARCOMA) Using Too Much Debt?
Jun 08Is Arcoma AB (STO:ARCOMA) Potentially Undervalued?
Apr 27Does Arcoma (STO:ARCOMA) Have A Healthy Balance Sheet?
Dec 22Is Arcoma (STO:ARCOMA) Using Too Much Debt?
May 03These 4 Measures Indicate That Arcoma (STO:ARCOMA) Is Using Debt Extensively
Oct 28Is Arcoma (STO:ARCOMA) A Risky Investment?
Mar 17Is Arcoma AB (STO:ARCOMA) Potentially Undervalued?
Feb 04Have Insiders Sold Arcoma AB (STO:ARCOMA) Shares Recently?
Jan 14
Arcoma AB's (STO:ARCOMA) Stock's On An Uptrend: Are Strong Financials Guiding The Market?
Jan 12These 4 Measures Indicate That Arcoma (STO:ARCOMA) Is Using Debt Reasonably Well
Dec 17Estimating The Fair Value Of Arcoma AB (STO:ARCOMA)
Nov 21Revenue & Expenses BreakdownBeta
How Arcoma makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 172 | 9 | 45 | 0 |
| 31 Dec 23 | 163 | 3 | 45 | 0 |
| 30 Sep 23 | 153 | 0 | 46 | 0 |
| 30 Jun 23 | 146 | 0 | 45 | 0 |
| 31 Mar 23 | 138 | 1 | 44 | 0 |
| 31 Dec 22 | 125 | 2 | 43 | 0 |
| 30 Sep 22 | 105 | -6 | 44 | 0 |
| 30 Jun 22 | 99 | -10 | 44 | 0 |
| 31 Mar 22 | 105 | -11 | 44 | 0 |
| 31 Dec 21 | 117 | -7 | 45 | 0 |
| 30 Sep 21 | 126 | -6 | 45 | 0 |
| 30 Jun 21 | 125 | -2 | 44 | 0 |
| 31 Mar 21 | 121 | -1 | 41 | 0 |
| 31 Dec 20 | 117 | 1 | 38 | 0 |
| 30 Sep 20 | 122 | 8 | 34 | 0 |
| 30 Jun 20 | 130 | 10 | 36 | 0 |
| 31 Mar 20 | 132 | 10 | 38 | 0 |
| 31 Dec 19 | 134 | 7 | 39 | 0 |
| 30 Sep 19 | 133 | 5 | 40 | 0 |
| 30 Jun 19 | 132 | 2 | 40 | 0 |
| 31 Mar 19 | 129 | 1 | 41 | 0 |
| 31 Dec 18 | 119 | -2 | 42 | 0 |
| 30 Sep 18 | 111 | -1 | 42 | 0 |
| 30 Jun 18 | 98 | -6 | 42 | 0 |
| 31 Mar 18 | 94 | -10 | 41 | 0 |
| 31 Dec 17 | 92 | -10 | 40 | 0 |
| 30 Sep 17 | 98 | -9 | 41 | 0 |
| 30 Jun 17 | 108 | -4 | 42 | 0 |
| 31 Mar 17 | 106 | -5 | 45 | 0 |
| 31 Dec 16 | 102 | -12 | 47 | 0 |
| 30 Sep 16 | 106 | -12 | 49 | 0 |
| 30 Jun 16 | 105 | -13 | 48 | 0 |
| 31 Mar 16 | 104 | -15 | 48 | 0 |
| 31 Dec 15 | 123 | -6 | 49 | 0 |
| 30 Sep 15 | 117 | -6 | 47 | 0 |
| 30 Jun 15 | 119 | -5 | 46 | 0 |
| 31 Mar 15 | 133 | 1 | 47 | 0 |
| 31 Dec 14 | 130 | 1 | 45 | 0 |
| 30 Sep 14 | 134 | -7 | 48 | 0 |
| 31 Dec 13 | 108 | -14 | 50 | 0 |
Quality Earnings: ARCOMA has high quality earnings.
Growing Profit Margin: ARCOMA's current net profit margins (5.5%) are higher than last year (0.6%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: ARCOMA has become profitable over the past 5 years, growing earnings by -22.2% per year.
Accelerating Growth: ARCOMA's earnings growth over the past year (1110%) exceeds its 5-year average (-22.2% per year).
Earnings vs Industry: ARCOMA earnings growth over the past year (1110%) exceeded the Medical Equipment industry 59.4%.
Return on Equity
High ROE: ARCOMA's Return on Equity (17.8%) is considered low.